City
Epaper

Vaccine for cervical cancer prevention to be available in small quantity in 2023, increased next year: Adar Poonawalla

By ANI | Updated: January 25, 2023 21:50 IST

A day after the launch of the first made-in-India Human Papillomavirus (HPV) "CERVAVAC" vaccine for the prevention of cervical ...

Open in App

A day after the launch of the first made-in-India Human Papillomavirus (HPV) "CERVAVAC" vaccine for the prevention of cervical cancer, Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla on Wednesday said that the availability of the vaccine will be little in number this year, however, it would be boosted next year.

Poonawalla briefed Union Health Minister Mansukh Mandaviya about the HPV vaccine in the national capital.

Speaking toafter the meeting, the SII CEO said, "I had come to brief the Union Health minister about it. We'll wait for the government program to roll out. Capacity is very small this year but we'll build a large capacity to take care of the entire nation's needs for next year."

Talking about the rollout programme of the vaccine, Poonawalla said that it would be done through government programmes this year.

"We will slowly roll it out through government programs this year. I can't comment on pricing now. We will wait for tendering process and follow government protocols," he said.

On Tuesday Serum Institute of India launched first made-in-India HPV vaccine for cervical cancer.

Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla, announced the launch of the first made-in-India Human Papillomavirus (HPV) "CERVAVAC" vaccine, for the prevention of cervical cancer.

The launch took place in the presence of Home Minister Amit Shah, Adar Poonawalla, and the Director of Government & Regulatory Affairs at Serum Institute of India, Prakash K Singh.

"On the occasion of India's National Girl Child Day and Cervical Cancer Awareness Month, @SerumInstIndia is pleased to launch the first made-in-India HPV vaccine by the hands of our Hon'ble Home Minister Shri @AmitShah Ji. @PrakashKsingh7," tweeted Adar Poonawalla.

'CERVAVAC' is an outcome of a partnership of DBT and BIRAC with the Bill and Melinda Gates Foundation, supported by Serum Institute of India Private Limited for the indigenous development of quadrivalent vaccine through its partnership programme 'Grand Challenges India'.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Mansukh MandaviyaSIISerum Institute Of IndiaSerum institute of india pvt. ltdAdar PoonawallaSerum indiaSerum institute of india private ltd.India serum institute of indiaSerum institute indiaSerum institute of india private limited
Open in App

Related Stories

EntertainmentKaran Johar's Dharma Productions Sells 50% Stake To Adar Poonawalla For ₹ 1000 Crore

NationalSports Minister Mansukh Mandaviya Felicitates Olympic Bronze Medallist Aman Sehrawat in Delhi (Watch Video)

NationalSports Minister Mansukh Mandaviya Felicitates Indian Men's Hockey Team in Delhi (Watch Video)

Other SportsManu Bhaker Awarded ₹30 Lakh After Winning Two Bronze Medals at Paris Olympics 2024 (See Pics)

Other SportsPM Modi Meets Indian Contingent Heading to Paris Olympics 2024 (Watch Video)

National Realted Stories

NationalAdopt precautions to deal with fire at Bandhwari landfill site in Gurugram: Deputy Commissioner

NationalHindu groups in Bhopal call for protest against 'love-jihad' today

NationalHindu activist murder case: Police deployed to Karnataka's Mangaluru; three teams hunt for accused

NationalAnother Nepali female student found dead at KIIT University in Bhubaneswar

NationalMP to strengthen farm-food sector ties; Mandsaur to host summit on May 3, Global Conclave in October